Pharma & Biotech

All eyes are on Danish pharmaceutical giant Novo Nordisk this week as it prepares to release its fourth-quarter 2025 financial...

Crinetics Pharmaceuticals has begun the year on a high note, with its first commercial product, PALSONIFY, delivering sales that exceeded...

Investor attention is turning to Bio-Rad Laboratories as the company prepares to release its fourth-quarter and full-year 2025 financial results....

All eyes are on pharmaceutical distribution giant Cencora this week as it prepares to release its first-quarter 2026 financial results....

Elanco Animal Health is entering the new trading month with significant momentum. A combination of raised price targets from major...

As the life sciences tools sector anticipates a recovery in biotech funding, Bio-Techne is executing a strategic shift. The company...

A significant regulatory roadblock has been removed for Intellia Therapeutics. The U.S. Food and Drug Administration (FDA) has lifted the...

A significant regulatory milestone has been achieved by BioNTech in the United States, providing fresh impetus for one of its...

Positive developments in oncology and an analyst upgrade are providing a lift for GE Healthcare Technologies shares as the company...

As it enters the 2026 fiscal year, Agilent Technologies is sharpening its strategic focus on technological specialization and operational efficiency....